Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict

Today's top gainers in the biotech space include NextCure, ahead of its planned merger with a private company that will create a newly branded public entity; Basel Medical, which recently regained Nasdaq compliance; and Outlook Therapeutics, which is awaiting an FDA decision expected by the end of the month, among others.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.